Eva L. Feldman, M.D., Ph.D., is the Russell N. DeJong Professor of Neurology at Michigan Medicine. A renowned neurologist and neuroscientist, she has devoted her career to understanding neurological disorders and developing new treatments. Dr. Feldman earned her medical and doctoral degrees at U-M and completed her neurology residency at Johns Hopkins Hospital. She joined the U-M faculty in 1988.
Dr. Feldman has more than 30 years of continuous funding from the National Institutes of Health for her research on neurological disorders. She is a principal investigator on the first two U.S. Food and Drug Administration-approved stem cell transplant clinical trials for ALS. She is also supported by the Centers for Disease Control and Prevention for her groundbreaking work on identifying environmental pollutants as a contributing cause of ALS.
Dr. Feldman was the inaugural director of the A. Alfred Taubman Medical Research Institute at U-M. She is a member of the National Academy of Medicine. In 2019, she received the Michigan Medicine Alumni Society’s Distinguished Achievement Award.
